Commentary

Provincialism holds back Europe's biotech sector

Read more

A strategy for raising response rates to immunotherapy

Read more

How a lung delivery issue unlocked RNA

Read more

New opportunities awaited travellers to San Francisco

Read more

Reviving the promise of dendritic cell therapies

Read more

Interoperability - a way to improve clinical trials

Read more

Biotechs shift priorities amidst financing challenges

Read more

Commentary: FDA guides industry on psychedelic drugs

Read more

Commentary: The analysis of biopharma R&D needs to be improved

Read more

How creative incubation supports life science in UK

Read more